Maddy is experienced in both qualitative and quantitative research across a wide range of therapy areas, including rare diseases, oncology and haematology.

Previous work has involved supporting in the development of a European launch strategy for a new gene therapy, understanding the appropriate economic modelling technique for the long-term extrapolation of overall survival, and developing insights into the European requirements for a phase III clinical development programme.

Maddy has experience in project management, most recently demonstrated through the leadership of a pro bono programme advocating for action to improve health outcomes for sickle cell and young stroke patients.

Maddy completed her BSc Biomedical sciences degree at the University of Manchester, including an industrial placement year in the Central Nervous System Diseases department at Boehringer Ingelheim.

‍

“I am excited to use innovative market research tools in order to help patients gain faster access to potentially life-changing drugs and health technologies”